Stock listing
NASDAQ:APLT Applied Therapeutics Inc Stock
Follow Applied Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:APLT
$0.103 USD
Close on Feb 2, 2026 · No longer trades
- Lowest – highest close
- $0.093 – $55.470 USDSince May 14, 2019 · lowest Jan 27, 2026 · highest Feb 5, 2020
Delisted NASDAQ:APLT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:APLT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Applied Therapeutics Inc on 6ix
- Decks
- 5 decks · latest Mar 11, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2024) | Investor deck | 43 slides | Mar 11, 2024 |
| Technical Presentation (March 2024) | Technical | 11 slides | Mar 11, 2024 |
| Technical Presentation (April 2023) | Technical | 16 slides | Apr 24, 2023 |
| Investor Presentation (February 2022) | Investor deck | 38 slides | Feb 15, 2022 |
| Technical Presentation (April 2020) | Technical | 39 slides | Apr 21, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John H. Johnson Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Melinta Therapeutics Inc (Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past) | Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past |
| Joel S. Marcus Other companies: TRex Bio, Inc. (Director · Since at least Oct 13, 2026); Alexandria Real Estate Equities, Inc. (Executive Chairman & Founder · Since at least May 9, 2007); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); MeiraGTx Holdings plc (Director · Jun 8, 2018 – Jun 7, 2022 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – Mar 15, 2019 · Past); Intra-Cellular Therapies Inc (Director · Sep 9, 2013 – Apr 2, 2025 · Past); Rexford Industrial Realty, Inc. (Director · Jul 18, 2013 – May 30, 2014 · Past); PennyMac Mortgage Investment Trust (Director · Aug 4, 2009 – May 16, 2012 · Past) | Director · May 13, 2019 – Jun 6, 2024 · Past |
| Constantine Chinoporos Other companies: enGene Therapeutics Inc. (Interim Chief Business Officer · Since at least Jul 16, 2026); Geron Corporation (Director · Since at least Mar 25, 2026) | See Remarks · Since at least Dec 28, 2023 |
| Jay Skyler Other companies: SAB Biotherapeutics, Inc. (Director · Since at least Dec 16, 2025) | Director · Since at least Jun 9, 2025 |
| Leslie D Funtleyder Other companies: Reviva Pharmaceuticals Holdings, Inc. (Director · Since at least Jun 15, 2021) | Chief Financial Officer, Director · Since at least Oct 1, 2020 |
| Mark J Vignola Other companies: Terns Pharmaceuticals, Inc. (Chief Financial Officer · Feb 4, 2021 – Jan 2, 2025 · Past) | Chief Financial Officer · May 13, 2019 – May 13, 2019 · Past |
| Stacy J. Kanter Other companies: Oppenheimer Holdings, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Oct 25, 2023) | Director · Since at least May 13, 2019 |
| Adam Hansard | Chief Commercial Officer · Mar 2, 2020 – Mar 14, 2024 · Past |
| Catherine Thorpe | Chief Accounting Officer · Jun 16, 2023 – Jun 16, 2023 · Past |
| Charles Silberstein | Chief Financial Officer · May 20, 2020 – Jan 7, 2022 · Past |
All 15 people
| Person | Seat |
|---|---|
| Chids Mahadevan | See Remarks · Apr 1, 2020 – Aug 2, 2022 · Past |
| Evan Prescott Bailey | Chief Medical Officer · Since at least Jun 15, 2025 |
| Riccardo Perfetti | Chief Medical Officer · May 13, 2019 – Mar 4, 2025 · Past |
| Steven A Ortega | Principal Accounting Officer · Mar 8, 2022 – Nov 15, 2022 · Past |
| Teena Lerner | Director · Since at least May 13, 2019 |
Log in to ask 6ix AI your own questions about Applied Therapeutics Inc.